We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current TNDM market cap is 3.21B. The company's latest EPS is USD -3.3919 and P/E is -14.41.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 169.38M | 195.92M | 185.62M | 196.8M | 191.67M |
| Operating Income | -127.82M | -38.81M | -31.55M | -35.06M | -41.68M |
| Net Income | -123.87M | -35.78M | -32.96M | -30M | -42.72M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 362.31M | 498.83M | 702.8M | 801.22M | 747.72M |
| Operating Income | -16.72M | -7.96M | 22.65M | -92.85M | -233.23M |
| Net Income | -24.75M | -34.38M | 15.57M | -94.59M | -222.61M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 954.15M | 946.68M | 939.91M | 952.66M | 941.05M |
| Total Liabilities | 615.39M | 617.44M | 625.91M | 639.03M | 697.98M |
| Total Equity | 338.75M | 329.23M | 314M | 313.63M | 243.06M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 326.11M | 716.42M | 905.14M | 1.05B | 952.66M |
| Total Liabilities | 131.13M | 350.11M | 472.03M | 612.84M | 639.03M |
| Total Equity | 194.98M | 366.31M | 433.11M | 439.95M | 313.63M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -18.33M | -24.65M | -24.59M | -31.81M | -8M |
| Investing | -26.33M | -20.63M | -69.16M | -85.74M | -5.06M |
| Financing | -541k | 3.41M | 1.5M | 4.11M | 13.59M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 41.91M | 24.67M | 111.36M | 50.46M | -31.81M |
| Investing | -56.96M | -296.06M | -186.88M | 33.17M | -85.74M |
| Financing | 24.21M | 314.44M | 51.93M | 16.88M | 4.11M |
| Market Cap | 3.21B |
| Price to Earnings Ratio | -14.41 |
| Price to Sales Ratio | 4.29 |
| Price to Cash Ratio | 54.48 |
| Price to Book Ratio | 10.23 |
| Dividend Yield | - |
| Shares Outstanding | 65.63M |
| Average Volume (1 week) | 1.17M |
| Average Volume (1 Month) | 1.48M |
| 52 Week Change | 98.05% |
| 52 Week High | 53.69 |
| 52 Week Low | 13.82 |
| Spread (Intraday) | 2.08 (4.14%) |
| Company Name | Tandem Diabetes Care Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.tandemdiabetes.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
